Medications Safe with SSRIs for Sleep

First-Line Pharmacologic Options

• The American Academy of Sleep Medicine recommends against the use of trazodone for SSRI-associated insomnia due to weak evidence from 50 mg dose trials 3
• Mirtazapine (7.5-30 mg at bedtime) is an alternative sedating antidepressant that promotes sleep, appetite, and weight gain, as recommended by the American Family Physician 4, 1, 2
• Zolpidem (5 mg at bedtime) is recommended for both sleep onset and maintenance insomnia by the Journal of the National Comprehensive Cancer Network 1, 2
• Eszopiclone (2-3 mg) is recommended for sleep onset and maintenance by the Praxis Medical Insights 3
• Zaleplon (10 mg) is recommended specifically for sleep onset insomnia only by the Praxis Medical Insights 3
• These agents have no significant serotonergic activity and do not interact with SSRIs through serotonin pathways, as stated by the Journal of Clinical Sleep Medicine 5

Critical Safety Considerations with SSRIs

• Do not combine two sedating antidepressants (e.g., trazodone + mirtazapine) as this carries significant risks including serotonin syndrome, excessive sedation, and QTc prolongation, as warned by the Praxis Medical Insights 3
• Sertraline and citalopram have the least drug interaction potential among SSRIs, according to the American Family Physician 4

Practical Prescribing Algorithm

• Start trazodone 25-50 mg at bedtime or mirtazapine 7.5-15 mg at bedtime if patient needs appetite stimulation or weight gain, as recommended by the Journal of the National Comprehensive Cancer Network and American Family Physician 1, 2, 4
• Switch to zolpidem 5 mg or eszopiclone 2 mg at bedtime if cardiac risk factors are present or trazodone/mirtazapine is ineffective, as recommended by the Journal of the National Comprehensive Cancer Network and Praxis Medical Insights 1, 2, 3

Common Pitfalls to Avoid

• Do not use over-the-counter antihistamines (diphenhydramine) or herbal supplements (valerian, melatonin) for chronic insomnia, as stated by the Journal of Clinical Sleep Medicine and Praxis Medical Insights 5, 3
• Do not prescribe barbiturates or chloral hydrate for insomnia, as warned by the Journal of Clinical Sleep Medicine 5
• Always use the lowest effective dose and reassess need for continued medication regularly, as recommended by the Journal of Clinical Sleep Medicine 5
• Be aware that SSRIs themselves can cause or worsen insomnia, which may require SSRI dose timing adjustment, as noted by the American Family Physician 4